Want to create an interactive transcript for this episode?
Podcast: The Gender Justice Brief
Episode: Bill updates and unpacking the FDA lawsuits
Description: In this episode, Erin Hart, Megan Peterson, and Jess Braverman discuss:
The FDA approved Mifepristone for as part of a two-drug regimen for medication abortion in 2000 with unnecessary restrictions, but during the pandemic, the FDA relaxed rules allowing telemedicine access to the medication.
After the Supreme Court overturned Roe v. Wade, ending the federal right to abortion, an anti-abortion group went after medication abortion in a manufactured lawsuit Alliance for Hippocratic Medicine vs. FDA.
Chaos and confusion, inhibiting access to medication abortion, is the current goal of the anti-abortion movement and lawmakers. This is impacting...